IQMIND Portfolio of Companies

Beemedic is a global leader in manufacturing advanced brain scan equipment. Based in Switzerland, the company has achieved aggregate sales of over $50M  by providing cutting-edge tools for mental health professionals. Its FDA-approved technologies are transforming diagnostics and treatments in clinics worldwide.

IQMIND Clinics are designed to tackle complex mental health disorders while unlocking unparalleled brain performance. These full-scale clinics combine advanced diagnostics with cutting-edge treatments to address conditions such as PTSD, ADHD, anxiety, depression, TBI (traumatic brain injuries), and seizure disorders. Beyond treating disorders, IQMIND Clinics specialize in elite brain performance enhancement for athletes, executives, and individuals seeking to optimize focus, clarity, reaction time, and memory. Whether improving cognitive endurance for athletes or providing innovative recovery solutions for TBI, our clinics set the gold standard in brain optimization.

Mood Bar Clinics bring brain health to high-traffic areas like malls and airports. Offering 30-minute tune-ups to improve sleep, focus, and mental clarity, these clinics are redefining convenience and accessibility in mental wellness. With projected revenue of $1.2 billion by 2029, they’re reshaping how we think about brain fitness.

ProSports Technologies uses patented motion-based analytics to enhance athlete safety and performance. Partnering with the NFL Players Association, the division is leading the charge in impact detection and real-time injury prevention for professional sports.

The HBI Database is the largest repository of neuroimaging and brain performance data in the world. It powers research, innovation, and clinical breakthroughs with AI-driven insights.

is at the forefront of research into the synergy between brain electricity and body chemistry, unlocking human potential and addressing mental health disorders. By leveraging advanced brainwave studies and innovative approaches, our therapies deliver remarkable outcomes, including a 44% reduction in depression and a 47% decrease in anxiety. As leaders in mental health innovation, we are redefining the future of therapeutic solutions and elevating the possibilities for brain and body optimization.